Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study to Assess the Efficacy and Safety of SpotOn Specs™ for the Treatment of Chronic Dizziness

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
SpotOn Therapeutics LTD
Information provided by (Responsible Party):
carlos gordon, Meir Medical Center
ClinicalTrials.gov Identifier:
NCT01460121
First received: October 25, 2011
Last updated: April 5, 2016
Last verified: April 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: October 2016
  Primary Completion Date: October 2015 (Final data collection date for primary outcome measure)